v3.26.1
Consolidated Statements of Changes in Shareholders’ (Deficit) Equity - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Preferred Stock
Total
Balance at Sep. 30, 2023 $ 144 $ 24,856 $ (5,325)   $ 19,675
Balance (in Shares) at Sep. 30, 2023 1,437,500        
Issuance of Private Placement Units $ 23 2,279,977   2,280,000
Issuance of Private Placement Units (in Shares) 228,000          
Issuance of representative shares $ 23 301,277   301,300
Issuance of representative shares (in Shares) 230,000          
Issuance of Public Rights, net of issuance cost of $45,930 1,219,070   1,219,070
Transfer Class B shares to independent directors 38,479   38,479
Accretion of carrying value to redemption value   (1,249,259)   (1,249,259)
Net income 255,721   255,721
Balance at Sep. 30, 2024 $ 46 $ 144 2,614,400 250,396 2,864,986
Balance (in Shares) at Sep. 30, 2024 458,000 1,437,500 [1]      
Accretion of carrying value to redemption value     (2,614,400) (1,406,224) (4,020,624)
Net income       1,304,272 1,304,272
Balance at Jun. 30, 2025 $ 46 $ 144   148,444 148,634
Balance (in Shares) at Jun. 30, 2025 458,000 1,437,500 [1]      
Balance at Sep. 30, 2024 $ 46 $ 144 2,614,400 250,396 2,864,986
Balance (in Shares) at Sep. 30, 2024 458,000 1,437,500 [1]      
Accretion of carrying value to redemption value (2,614,400) (1,796,612)   (4,411,012)
Extension fees deposited into trust account       (450,000)   (450,000)
Net income 1,370,753   1,370,753
Balance at Sep. 30, 2025 $ 46 $ 144 (625,463)   (625,273)
Balance (in Shares) at Sep. 30, 2025 458,000 1,437,500        
Accretion of carrying value to redemption value       (850,709)   (850,709)
Term extension fee       (1,350,000)   (1,350,000)
Net income       110,299   110,299
Balance at Jun. 30, 2026 $ 46 $ 144   $ (2,715,873)   $ (2,715,683)
Balance (in Shares) at Jun. 30, 2026 458,000 1,437,500        
[1] Retroactively restated to include an aggregate of 187,500 Class B ordinary shares as a result of the underwriter’s full exercise of their over-allotment option on July 8, 2024. No Founder Shares are currently subject to forfeiture